132 related articles for article (PubMed ID: 3369622)
1. Cytotoxicity of dimethyl sulfoxide and antineoplastic combinations against human tumors.
Pommier RF; Woltering EA; Milo G; Fletcher WS
Am J Surg; 1988 May; 155(5):672-6. PubMed ID: 3369622
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity between dimethyl sulfoxide and antineoplastic agents against ovarian cancer in vitro.
Pommier RF; Woltering EA; Milo G; Fletcher WS
Am J Obstet Gynecol; 1988 Oct; 159(4):848-52. PubMed ID: 3177534
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cytotoxicity of combinations of dimethyl sulfoxide and antineoplastic agents against P388 leukemia in CD-F1 mice.
Pommier RF; Woltering EA; Milo G; Fletcher WS
Anticancer Drugs; 1992 Dec; 3(6):635-9. PubMed ID: 1288734
[TBL] [Abstract][Full Text] [Related]
4. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
6. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
8. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity.
See WA; Xia Q
J Natl Cancer Inst; 1992 Apr; 84(7):510-5. PubMed ID: 1545441
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
Tsukuda M; Mochimatsu I; Kokatsu T; Ito K; Furukawa S; Inoue T; Watanabe S; Sawaki S
Gan To Kagaku Ryoho; 1992 Apr; 19(4):553-6. PubMed ID: 1373052
[No Abstract] [Full Text] [Related]
10. Tumor necrosis factor and cytotoxic agents. Effect on squamous carcinoma lines.
Gapany M; Dawson DE; Schriever C; Burgess R; Gipple JR; Riggs CE
Arch Otolaryngol Head Neck Surg; 1990 Apr; 116(4):436-9. PubMed ID: 2317326
[TBL] [Abstract][Full Text] [Related]
11. [Basic study on the sensitivity test for inhibiting fibroblast proliferation (II)].
Sato Y; Kondo T; Yamada F
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1885-90. PubMed ID: 11729481
[TBL] [Abstract][Full Text] [Related]
12. L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human Breast Cancer Cells.
Nurcahyanti AD; Wink M
Anticancer Agents Med Chem; 2017; 17(2):206-211. PubMed ID: 26902604
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl sulfoxide inactivates the anticancer effect of cisplatin against human myelogenous leukemia cell lines in in vitro assays.
Raghavan R; Cheriyamundath S; Madassery J
Indian J Pharmacol; 2015; 47(3):322-4. PubMed ID: 26069372
[TBL] [Abstract][Full Text] [Related]
14. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.
Lin TS; Ishiguro K; Sartorelli AC
Oncol Res; 1998; 10(4):175-84. PubMed ID: 9778688
[TBL] [Abstract][Full Text] [Related]
15. Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro.
Hill BT; Bellamy AS; Metcalfe S; Hepburn PJ; Masters JR; Whelan RD
Invest New Drugs; 1984; 2(1):29-33. PubMed ID: 6540761
[TBL] [Abstract][Full Text] [Related]
16. Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells.
Frost P; Abbruzzese JL; Hunt B; Lee D; Ellis M
Cancer Res; 1990 Aug; 50(15):4572-7. PubMed ID: 1695122
[TBL] [Abstract][Full Text] [Related]
17. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design.
Chou TC; Motzer RJ; Tong Y; Bosl GJ
J Natl Cancer Inst; 1994 Oct; 86(20):1517-24. PubMed ID: 7932806
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions of combinations of topotecan with standard drugs in primary cultures of human tumor cells from patients.
Jonsson E; Fridborg H; Nygren P; Larsson R
Eur J Clin Pharmacol; 1998 Sep; 54(7):509-14. PubMed ID: 9832291
[TBL] [Abstract][Full Text] [Related]
19. Anticancer chemosensitivity changes between the original and recurrent tumors after successful chemotherapy selected according to the sensitivity assay.
Nio Y; Tamura K; Tsubono M; Kawabata K; Masai Y; Hayashi H; Ishigami S; Araya S; Imamura M
Ann Surg; 1995 Jan; 221(1):89-99. PubMed ID: 7826166
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
